Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Apr;80(1-2):142–148. doi: 10.1038/sj.bjc.6690333

Effects of radiotherapy and estramustine on the microvasculature in malignant glioma

M Johansson 1, A T Bergenheim 2, A Widmark 1, R Henriksson 1
PMCID: PMC2362991  PMID: 10389990

Abstract

Tumour angiogenesis is essential for progression of solid tumours and constitutes an interesting target for therapy. However, impaired tumour blood supply may also be an important obstacle for treatment by radiotherapy and chemotherapy. Estramustine has been shown to increase tumour blood flow and potentiate the effect of radiotherapy in experimental glioma. This study investigated the effects of fractionated radiotherapy and estramustine on angiogenesis in malignant glioma. The intracerebral BT4C rat glioma model was used and the animals were given whole brain radiotherapy 4 Gy × 5 days alone or in combination with estramustine 20 mg kg-1 i.p. daily. Tumour microvascular density (MVD) was assessed by manual and computerized morphometrical analysis. Expression of vascular endothelial growth factor (VEGF) was studied by in situ hybridization. Radiotherapy decreased MVD to 157 vessels per mm2 compared to 217 vessels per mm2 in controls. Estramustine counteracted this anti-angiogenic effect and potentiated the anti-tumoural effect of radiotherapy. In addition, vessel size increased after estramustine treatment. Five days after completion of radiotherapy the expression of VEGF was increased in the centre of the tumours. In conclusion, fractionated radiotherapy decreases microvascular density in experimental malignant glioma. This effect was abolished by estramustine. The anti-vascular effect of irradiation is important to recognize when combining radiotherapy with cytotoxic drugs. © 1999 Cancer Research Campaign

Keywords: angiogenesis, chemotherapy, glioma, radiotherapy, VEGF

Full Text

The Full Text of this article is available as a PDF (235.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker D. G., Krochak R. J. The response of the microvascular system to radiation: a review. Cancer Invest. 1989;7(3):287–294. doi: 10.3109/07357908909039849. [DOI] [PubMed] [Google Scholar]
  2. Banerjee S. K., Sarkar D. K., Weston A. P., De A., Campbell D. R. Over expression of vascular endothelial growth factor and its receptor during the development of estrogen-induced rat pituitary tumors may mediate estrogen-initiated tumor angiogenesis. Carcinogenesis. 1997 Jun;18(6):1155–1161. doi: 10.1093/carcin/18.6.1155. [DOI] [PubMed] [Google Scholar]
  3. Bergenheim A. T., Björk P., Bergh J., von Schoultz E., Svedberg H., Henriksson R. Estramustine-binding protein and specific binding of the anti-mitotic compound estramustine in astrocytoma. Cancer Res. 1994 Sep 15;54(18):4974–4979. [PubMed] [Google Scholar]
  4. Bergenheim A. T., Gunnarsson P. O., Edman K., von Schoultz E., Hariz M. I., Henriksson R. Uptake and retention of estramustine and the presence of estramustine binding protein in malignant brain tumours in humans. Br J Cancer. 1993 Feb;67(2):358–361. doi: 10.1038/bjc.1993.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bergenheim A. T., Henriksson R., Piepmeier J. M., Yoshida D. Estramustine in malignant glioma. J Neurooncol. 1996 Oct;30(1):81–89. doi: 10.1007/BF00177446. [DOI] [PubMed] [Google Scholar]
  6. Bergenheim A. T., Zackrisson B., Elfverson J., Roos G., Henriksson R. Radiosensitizing effect of estramustine in malignant glioma in vitro and in vivo. J Neurooncol. 1995;23(3):191–200. doi: 10.1007/BF01059950. [DOI] [PubMed] [Google Scholar]
  7. Cullinan-Bove K., Koos R. D. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology. 1993 Aug;133(2):829–837. doi: 10.1210/endo.133.2.8344219. [DOI] [PubMed] [Google Scholar]
  8. Denekamp J., Hobson B. Endothelial-cell proliferation in experimental tumours. Br J Cancer. 1982 Nov;46(5):711–720. doi: 10.1038/bjc.1982.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Denekamp J. The current status of targeting tumour vasculature as a means of cancer therapy: an overview. Int J Radiat Biol. 1991 Jul-Aug;60(1-2):401–408. doi: 10.1080/09553009114552251. [DOI] [PubMed] [Google Scholar]
  10. Dewhirst M. W., Oliver R., Tso C. Y., Gustafson C., Secomb T., Gross J. F. Heterogeneity in tumor microvascular response to radiation. Int J Radiat Oncol Biol Phys. 1990 Mar;18(3):559–568. doi: 10.1016/0360-3016(90)90061-n. [DOI] [PubMed] [Google Scholar]
  11. Ferrara N. Vascular endothelial growth factor. Eur J Cancer. 1996 Dec;32A(14):2413–2422. doi: 10.1016/s0959-8049(96)00387-5. [DOI] [PubMed] [Google Scholar]
  12. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971 Nov 18;285(21):1182–1186. doi: 10.1056/NEJM197111182852108. [DOI] [PubMed] [Google Scholar]
  13. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 1990 Jan 3;82(1):4–6. doi: 10.1093/jnci/82.1.4. [DOI] [PubMed] [Google Scholar]
  14. GRAY L. H. Radiobiologic basis of oxygen as a modifying factor in radiation therapy. Am J Roentgenol Radium Ther Nucl Med. 1961 May;85:803–815. [PubMed] [Google Scholar]
  15. Gasparini G., Harris A. L. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol. 1995 Mar;13(3):765–782. doi: 10.1200/JCO.1995.13.3.765. [DOI] [PubMed] [Google Scholar]
  16. Henderson S. D., Kimler B. F., Morantz R. A. Radiation therapy of 9L rat brain tumors. Int J Radiat Oncol Biol Phys. 1981 Apr;7(4):497–502. doi: 10.1016/0360-3016(81)90136-x. [DOI] [PubMed] [Google Scholar]
  17. Hilmas D. E., Gillette E. L. Tumor microvasculature following fractionated x irradiation. Radiology. 1975 Jul;116(1):165–169. doi: 10.1148/116.1.165. [DOI] [PubMed] [Google Scholar]
  18. Jain R. K. Transport of molecules across tumor vasculature. Cancer Metastasis Rev. 1987;6(4):559–593. doi: 10.1007/BF00047468. [DOI] [PubMed] [Google Scholar]
  19. Johansson M., Bergenheim A. T., D'Argy R., Edman K., Gunnarsson P. O., Widmark A., Henriksson R. Distribution of estramustine in the BT4C rat glioma model. Cancer Chemother Pharmacol. 1998;41(4):317–325. doi: 10.1007/s002800050745. [DOI] [PubMed] [Google Scholar]
  20. Johansson M., Bergenheim A. T., Henriksson R., Koskinen L. O., Vallbo C., Widmark A. Tumor blood flow and the cytotoxic effects of estramustine and its constituents in a rat glioma model. Neurosurgery. 1997 Jul;41(1):237–244. doi: 10.1097/00006123-199707000-00038. [DOI] [PubMed] [Google Scholar]
  21. Kelly P. J., Daumas-Duport C., Kispert D. B., Kall B. A., Scheithauer B. W., Illig J. J. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg. 1987 Jun;66(6):865–874. doi: 10.3171/jns.1987.66.6.0865. [DOI] [PubMed] [Google Scholar]
  22. Leon S. P., Folkerth R. D., Black P. M. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer. 1996 Jan 15;77(2):362–372. doi: 10.1002/(SICI)1097-0142(19960115)77:2<362::AID-CNCR20>3.0.CO;2-Z. [DOI] [PubMed] [Google Scholar]
  23. Lindgren M., Johansson M., Sandström J., Jonsson Y., Bergenheim A. T., Henriksson R. VEGF and tPA co-expressed in malignant glioma. Acta Oncol. 1997;36(6):615–618. doi: 10.3109/02841869709001324. [DOI] [PubMed] [Google Scholar]
  24. Littbrand B., Révész L. The effect of oxygen on cellular survival and recovery after radiation. Br J Radiol. 1969 Dec;42(504):914–924. doi: 10.1259/0007-1285-42-504-914. [DOI] [PubMed] [Google Scholar]
  25. Morales D. E., McGowan K. A., Grant D. S., Maheshwari S., Bhartiya D., Cid M. C., Kleinman H. K., Schnaper H. W. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation. 1995 Feb 1;91(3):755–763. doi: 10.1161/01.cir.91.3.755. [DOI] [PubMed] [Google Scholar]
  26. Nakamura J., Savinov A., Lu Q., Brodie A. Estrogen regulates vascular endothelial growth/permeability factor expression in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. Endocrinology. 1996 Dec;137(12):5589–5596. doi: 10.1210/endo.137.12.8940388. [DOI] [PubMed] [Google Scholar]
  27. Plate K. H., Breier G., Millauer B., Ullrich A., Risau W. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res. 1993 Dec 1;53(23):5822–5827. [PubMed] [Google Scholar]
  28. Plate K. H., Breier G., Weich H. A., Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature. 1992 Oct 29;359(6398):845–848. doi: 10.1038/359845a0. [DOI] [PubMed] [Google Scholar]
  29. Prionas S. D., Kowalski J., Fajardo L. F., Kaplan I., Kwan H. H., Allison A. C. Effects of X irradiation on angiogenesis. Radiat Res. 1990 Oct;124(1):43–49. [PubMed] [Google Scholar]
  30. Rubin P., Casarett G. Microcirculation of tumors. II. The supervascularized state of irradiated regressing tumors. Clin Radiol. 1966 Oct;17(4):346–355. doi: 10.1016/s0009-9260(66)80052-1. [DOI] [PubMed] [Google Scholar]
  31. Seiler R. W., Zimmermann A., Bleher E. A., Markwalder H. Preoperative radiotherapy and chemotherapy in hypervascular, high-grade supratentorial astrocytomas. Surg Neurol. 1979 Aug;12(2):131–133. [PubMed] [Google Scholar]
  32. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992 Oct 29;359(6398):843–845. doi: 10.1038/359843a0. [DOI] [PubMed] [Google Scholar]
  33. Solesvik O. V., Rofstad E. K., Brustad T. Vascular changes in a human malignant melanoma xenograft following single-dose irradiation. Radiat Res. 1984 Apr;98(1):115–128. [PubMed] [Google Scholar]
  34. Song C. W., Sung J. H., Clement J. J., Levitt S. H. Vascular changes in neuroblastoma of mice following x-irradiation. Cancer Res. 1974 Sep;34(9):2344–2350. [PubMed] [Google Scholar]
  35. Weidner N. Tumor angiogenesis: review of current applications in tumor prognostication. Semin Diagn Pathol. 1993 Nov;10(4):302–313. [PubMed] [Google Scholar]
  36. Yoshida D., Piepmeier J., Weinstein M. Estramustine sensitizes human glioblastoma cells to irradiation. Cancer Res. 1994 Mar 15;54(6):1415–1417. [PubMed] [Google Scholar]
  37. Zywietz F. Vascular and cellular damage in a murine tumour during fractionated treatment with radiation and hyperthermia. Strahlenther Onkol. 1990 Jul;166(7):493–501. [PubMed] [Google Scholar]
  38. von Schoultz E., Lundblad D., Bergh J., Grankvist K., Henriksson R. Estramustine binding protein and anti-proliferative effect of estramustine in human glioma cell lines. Br J Cancer. 1988 Sep;58(3):326–329. doi: 10.1038/bjc.1988.212. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES